New federal law introduces significant changes in the design of pharmacy benefit plans with aims to level the playing field between PBMs and their employee healthcare benefit plan clients.
Dae Y. Lee, Esq.
Advertisement
Dae Y. Lee is a pharmacist attorney in Frier Levitt’s life sciences department.
Articles by Dae Y. Lee, Esq.
Advertisement
Latest Updated Articles
The Consolidated Appropriations Act and PBM TransparencyPublished: May 12th 2023 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharma Collaborations Focused on Advancing Antibody-Drug Conjugates and Delivering Treatments for Autoimmune Diseases
2
Roundup: Biopharma Funding Rounds Advance Clinical Development of Novel Therapy and Treatment Solutions
3
Pharmaceutical Executive Daily: Rethinking Workforce Development
4
Success Guide - Where Precision Meets Pressure: AI Roleplay Built for Pharma Field Teams
5
